Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02082509 · ClinicalTrials.gov registry record

Therapeutic Resources for Attention Improvement With Neuroimaging for TBI

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
26
Enrollment target

NCT02082509 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02082509 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

One of the most common symptoms suffered by traumatic brain injury (TBI) patients is disruption in attention. Lack of attention impacts daily life including academic or professional tasks, and interpersonal relationships. The focus of Therapeutic Resources for Attention Improvement with Neuroimaging for Traumatic Brain Injury (TRAIN-TBI) is to investigate the changes in neurological function with special interest in attention after TBI for children ages 8 to 16. This study will be done through advanced neuroimaging procedures, neurocognitive testing, and an online training tool created by The Brain Plasticity Institute. The investigators hypothesize that the training will improve attention in TBI subjects and that the advanced imaging will show corresponding neural connectivity changes, as compared to matched healthy controls.

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2014-03
Est. Completion 2015-03

What the Registry Record Tells You About NCT02082509

The ClinicalTrials.gov registry entry for NCT02082509 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02082509 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02082509 about?

NCT02082509 is a clinical study titled "Therapeutic Resources for Attention Improvement With Neuroimaging for TBI". One of the most common symptoms suffered by traumatic brain injury (TBI) patients is disruption in attention. Lack of attention impacts daily life including academic or professional tasks, and interpersonal relationships. The focus of Therapeutic Resources for Attention Improvement with Neuroimaging...

What is the current status of trial NCT02082509?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2014-03. Estimated completion is 2015-03.

Who is sponsoring clinical trial NCT02082509?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.